210 related articles for article (PubMed ID: 10853618)
21. Meropenem and continuous renal replacement therapy: in vitro permeability of 2 continuous renal replacement therapy membranes and influence of patient renal function on the pharmacokinetics in critically ill patients.
Isla A; Maynar J; Sánchez-Izquierdo JA; Gascón AR; Arzuaga A; Corral E; Pedraz JL
J Clin Pharmacol; 2005 Nov; 45(11):1294-304. PubMed ID: 16239363
[TBL] [Abstract][Full Text] [Related]
22. Myoglobin clearance and removal during continuous venovenous hemofiltration.
Amyot SL; Leblanc M; Thibeault Y; Geadah D; Cardinal J
Intensive Care Med; 1999 Oct; 25(10):1169-72. PubMed ID: 10551978
[TBL] [Abstract][Full Text] [Related]
23. CVVHD treatment with CARPEDIEM: small solute clearance at different blood and dialysate flows with three different surface area filter configurations.
Lorenzin A; Garzotto F; Alghisi A; Neri M; Galeano D; Aresu S; Pani A; Vidal E; Ricci Z; Murer L; Goldstein SL; Ronco C
Pediatr Nephrol; 2016 Oct; 31(10):1659-65. PubMed ID: 27139897
[TBL] [Abstract][Full Text] [Related]
24. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
Chadha V; Garg U; Warady BA; Alon US
Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
[TBL] [Abstract][Full Text] [Related]
25. Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure.
Level C; Chauveau P; Guisset O; Cazin MC; Lasseur C; Gabinsky C; Winnock S; Montaudon D; Bedry R; Nouts C; Pillet O; Benissan GG; Favarel-Guarrigues JC; Castaing Y
Crit Care; 2003 Dec; 7(6):R160-6. PubMed ID: 14624691
[TBL] [Abstract][Full Text] [Related]
26. Filtration of native and glycated beta2-microglobulin by charged and neutral dialysis membranes.
Randoux C; Gillery P; Georges N; Lavaud S; Chanard J
Kidney Int; 2001 Oct; 60(4):1571-7. PubMed ID: 11576375
[TBL] [Abstract][Full Text] [Related]
27. Etanercept clearance during an in vitro model of continuous venovenous hemofiltration.
Fleming GM; Salama NN; Eid SK; Cooke KR; Mueller BA
Blood Purif; 2009; 28(4):348-53. PubMed ID: 19729904
[TBL] [Abstract][Full Text] [Related]
28. [Determination of elimination of pefloxacin and of its derivatives in continuous hemodiafiltration].
Journois D; Chanu D; Ruat JM; Ballereau M; Garraffo R; Safran D
Pathol Biol (Paris); 1991 Apr; 39(4):260-3. PubMed ID: 2062549
[TBL] [Abstract][Full Text] [Related]
29. [Effect of continuous renal replacement therapy on the plasma concentration of imipenem in severe infection patients with acute renal injury].
Yu B; Liu L; Xing D; Zhao C; Hu Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):359-65. PubMed ID: 26003640
[TBL] [Abstract][Full Text] [Related]
30. In vivo Elimination of Clonidine by Continuous Venovenous Hemofiltration in Critically Ill Patients.
van den Oever HLA; Zeeman M; Nassikovker P; Bles C; van Steveninck FAL; de Meijer AR; Kruisdijk-Gerritsen A; Arbouw M
Blood Purif; 2020; 49(5):622-626. PubMed ID: 31962323
[TBL] [Abstract][Full Text] [Related]
31. Ceftriaxone pharmacokinetic properties during continuous veno-veno haemofiltration using an in vitro adult, paediatric and neonatal model.
Harvey B; Johnson TN; Yeomanson D; Mulla H; Mayer AP
Perfusion; 2014 Jan; 29(1):32-8. PubMed ID: 23863489
[TBL] [Abstract][Full Text] [Related]
32. Diffusive vs. convective therapy: effects on mediators of inflammation in patient with severe systemic inflammatory response syndrome.
Kellum JA; Johnson JP; Kramer D; Palevsky P; Brady JJ; Pinsky MR
Crit Care Med; 1998 Dec; 26(12):1995-2000. PubMed ID: 9875910
[TBL] [Abstract][Full Text] [Related]
33. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis.
Maxvold NJ; Smoyer WE; Custer JR; Bunchman TE
Crit Care Med; 2000 Apr; 28(4):1161-5. PubMed ID: 10809299
[TBL] [Abstract][Full Text] [Related]
34. Clearance of ceftriaxone during haemodialysis using cuprophane, haemophane and polysulfone dialysers.
Gabutti L; Taminelli-Beltraminelli L; Marone C
Eur J Clin Pharmacol; 1997; 53(2):123-6. PubMed ID: 9403283
[TBL] [Abstract][Full Text] [Related]
35. Ex vivo Rezafungin Adsorption and Clearance During Continuous Renal Replacement Therapy.
Jang SM; Hough G; Mueller BA
Blood Purif; 2018; 46(3):214-219. PubMed ID: 30048960
[TBL] [Abstract][Full Text] [Related]
36. Acetaminophen clearance during ex vivo continuous renal replacement therapies.
Scoville BA; Vulaj V; Mueller BA; Annich GM; Wagner DS
J Artif Organs; 2018 Jun; 21(2):215-219. PubMed ID: 29063343
[TBL] [Abstract][Full Text] [Related]
37. Dialysate and blood flow dependence of diffusive solute clearance during CVVHD.
Relton S; Greenberg A; Palevsky PM
ASAIO J; 1992; 38(3):M691-6. PubMed ID: 1457951
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy.
Pasko DA; Churchwell MD; Salama NN; Mueller BA
Blood Purif; 2011; 32(2):82-8. PubMed ID: 21372565
[TBL] [Abstract][Full Text] [Related]
39. Iohexol transmembrane clearance during modeled continuous renal replacement therapy.
Yardman-Frank JM; Mercier RC; Wong CS; Vilay AM
Blood Purif; 2015; 39(1-3):188-192. PubMed ID: 25765443
[TBL] [Abstract][Full Text] [Related]
40. The simulation of continuous arteriovenous hemodialysis with a mathematical model.
Pallone TL; Hyver S; Petersen J
Kidney Int; 1989 Jan; 35(1):125-33. PubMed ID: 2709658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
